Wangyang Tu

506 total citations
16 papers, 421 citations indexed

About

Wangyang Tu is a scholar working on Organic Chemistry, Molecular Biology and Biological Psychiatry. According to data from OpenAlex, Wangyang Tu has authored 16 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 9 papers in Molecular Biology and 2 papers in Biological Psychiatry. Recurrent topics in Wangyang Tu's work include Catalytic C–H Functionalization Methods (4 papers), Catalytic Cross-Coupling Reactions (3 papers) and Oxidative Organic Chemistry Reactions (3 papers). Wangyang Tu is often cited by papers focused on Catalytic C–H Functionalization Methods (4 papers), Catalytic Cross-Coupling Reactions (3 papers) and Oxidative Organic Chemistry Reactions (3 papers). Wangyang Tu collaborates with scholars based in China, United States and Italy. Wangyang Tu's co-authors include Paul E. Floreancig, Lei Liu, Yubo Cui, Fanglong Yang, Zhiwei Liu, Hong Wan, Feng He, Bing Hu, Weikang Tao and Wei Peng and has published in prestigious journals such as Angewandte Chemie International Edition, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Wangyang Tu

14 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wangyang Tu China 8 375 69 58 33 24 16 421
Derek J. Denhart United States 15 461 1.2× 41 0.6× 156 2.7× 61 1.8× 7 0.3× 21 528
Yu Harayama Japan 9 304 0.8× 100 1.4× 58 1.0× 41 1.2× 6 0.3× 10 382
Neil F. Langille United States 9 305 0.8× 44 0.6× 61 1.1× 29 0.9× 12 0.5× 13 335
Bogonda Ganganna India 12 378 1.0× 42 0.6× 75 1.3× 61 1.8× 7 0.3× 23 466
Marie‐Isabelle Lannou France 12 402 1.1× 71 1.0× 103 1.8× 60 1.8× 10 0.4× 31 442
Manomi A. Tennakoon United States 7 278 0.7× 68 1.0× 137 2.4× 44 1.3× 23 1.0× 9 328
Adriana Lorente Spain 9 456 1.2× 60 0.9× 57 1.0× 35 1.1× 7 0.3× 16 504
Patrick J. McDougall United States 8 403 1.1× 57 0.8× 55 0.9× 47 1.4× 64 2.7× 8 430
Amy C. DeBaillie United States 8 219 0.6× 38 0.6× 65 1.1× 34 1.0× 15 0.6× 13 255

Countries citing papers authored by Wangyang Tu

Since Specialization
Citations

This map shows the geographic impact of Wangyang Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wangyang Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wangyang Tu more than expected).

Fields of papers citing papers by Wangyang Tu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wangyang Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wangyang Tu. The network helps show where Wangyang Tu may publish in the future.

Co-authorship network of co-authors of Wangyang Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Wangyang Tu. A scholar is included among the top collaborators of Wangyang Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wangyang Tu. Wangyang Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Xie, Qing, Mao-Zhi Yang, Shujuan Jiang, et al.. (2025). Identification of Novel 2-(Azetidin-3-ylamino)nicotinamide Derivatives as Potent KRAS::SOS1 Inhibitors. ACS Medicinal Chemistry Letters. 16(8). 1626–1633.
2.
Li, Jinɡjinɡ, Chaobo Zhang, Lei Liu, et al.. (2024). Discovery of orally bioavailable phosphonate prodrugs of potent ENPP1 inhibitors for cancer treatment. European Journal of Medicinal Chemistry. 279. 116853–116853. 1 indexed citations
3.
Li, Jinɡjinɡ, et al.. (2024). Discovery of Pyrazolo[1,5,4-de]quinoxalin-2(3H)-one Derivatives as Highly Potent and Selective PARP1 Inhibitors. Journal of Medicinal Chemistry. 67(23). 21380–21399. 2 indexed citations
4.
Xie, Qing, Mao-Zhi Yang, Shujuan Jiang, et al.. (2024). Lead Identification of Novel Naphthyridine Derivatives as Potent SOS1 Inhibitors. ACS Medicinal Chemistry Letters. 15(6). 958–964. 4 indexed citations
5.
Li, Dongsheng, Shujuan Jiang, Mao-Zhi Yang, et al.. (2024). Abstract LB031: Discovery and Characterization of HH100937, a potent and selective SOS1 inhibitor demonstrates synergistic efficacy in combination with KRAS/MAPK therapies. Cancer Research. 84(7_Supplement). LB031–LB031. 1 indexed citations
6.
Li, Jinɡjinɡ, et al.. (2024). Abstract LB032: HH102007 is a highly selective and potent PARP1 inhibitor and trapper. Cancer Research. 84(7_Supplement). LB032–LB032. 1 indexed citations
7.
Hu, Qiyue, Shenglan Wang, Wangyang Tu, et al.. (2021). Discovery of Hydroxyamidine Derivatives as Highly Potent, Selective Indoleamine-2,3-dioxygenase 1 Inhibitors. ACS Medicinal Chemistry Letters. 12(2). 195–201. 3 indexed citations
8.
Tu, Wangyang, Fanglong Yang, Zhiwei Liu, et al.. (2019). Discovery of Imidazoisoindole Derivatives as Highly Potent and Orally Active Indoleamine-2,3-dioxygenase Inhibitors. ACS Medicinal Chemistry Letters. 10(6). 949–953. 23 indexed citations
9.
Tu, Wangyang, Qiyue Hu, Lei Zhang, et al.. (2014). Structure-based design and synthesis of bicyclic fused-pyridines as MEK inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(11). 2555–2559. 5 indexed citations
10.
Tu, Wangyang, Zhiwei Liu, Jian Qu, et al.. (2013). Synthesis and biological evaluation of cyclopentyl-triazolol-pyrimidine (CPTP) based P2Y12 antagonists. Bioorganic & Medicinal Chemistry Letters. 24(1). 141–146. 12 indexed citations
11.
Cui, Yubo, Wangyang Tu, & Paul E. Floreancig. (2010). Total synthesis of neopeltolide and analogs. Tetrahedron. 66(26). 4867–4873. 36 indexed citations
12.
Tu, Wangyang & Paul E. Floreancig. (2009). Oxidative Carbocation Formation in Macrocycles: Synthesis of the Neopeltolide Macrocycle. Angewandte Chemie International Edition. 48(25). 4567–4571. 117 indexed citations
13.
Tu, Wangyang & Paul E. Floreancig. (2009). Oxidative Carbocation Formation in Macrocycles: Synthesis of the Neopeltolide Macrocycle. Angewandte Chemie. 121(25). 4637–4641. 43 indexed citations
14.
Tu, Wangyang, Lei Liu, & Paul E. Floreancig. (2008). Diastereoselective Tetrahydropyrone Synthesis through Transition‐Metal‐Free Oxidative Carbon–Hydrogen Bond Activation. Angewandte Chemie International Edition. 47(22). 4184–4187. 114 indexed citations
15.
Tu, Wangyang, Lei Liu, & Paul E. Floreancig. (2008). Diastereoselective Tetrahydropyrone Synthesis through Transition‐Metal‐Free Oxidative Carbon–Hydrogen Bond Activation. Angewandte Chemie. 120(22). 4252–4255. 44 indexed citations
16.
Tu, Wangyang & Paul E. Floreancig. (2007). Intramolecular Electron Transfer Initiated Cation and Radical Formation through Carbon−Carbon Bond Activation. Organic Letters. 9(12). 2389–2392. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026